A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract Bleeding
NCT07837713
Digestive System Diseases, Gastrointestinal Diseases
Mumbai, Maharashtra, India
View Trial DetailsNCT Number: NCT07822958
This prospective cohort study aims to determine the prevalence of gastrointestinal bleeding among critically ill patients admitted to intensive care units, identify independent risk factors, and describe clinical outcomes including ICU length of stay, transfusion requirements, and mortality at Assiut University Hospitals.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Gastrointestinal bleeding is a serious complication in critically ill patients and is associated with increased morbidity and mortality. This prospective observational cohort study will include adult patients (≥18 years) admitted to the intensive care units of Assiut University Hospitals.
Patients will be followed during their ICU stay for the occurrence of clinically important gastrointestinal bleeding (overt or occult) occurring ≥24 hours after admission. Clinical, laboratory, and treatment-related data will be collected to identify independent risk factors and to assess associated clinical outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 30 days
Proportion of critically ill patients who develop clinically important gastrointestinal bleeding (overt bleeding with hemodynamic compromise or significant hemoglobin drop, or occult bleeding confirmed by fecal occult blood test or endoscopy) occurring 24 hours or more after ICU admission.
Time frame: Up to 30 days
Odds ratios of clinical, laboratory, and treatment-related factors for the occurrence of clinically important gastrointestinal bleeding using multivariable logistic regression analysis.
Time frame: Up to 30 days
Duration of intensive care unit stay in days.
Time frame: Up to 30 days
Number of units of packed red blood cells transfused during the ICU stay.
Time frame: Up to 30 days
Proportion of patients who die during the ICU stay.
Time frame: Up to 30 days
Proportion of patients requiring endoscopic therapy or surgical intervention for gastrointestinal bleeding.
Trial opening soon.
Get NotifiedAssiut University
Other
Gastrointestinal Bleeding in Critically Ill Patients: Prevalence, Risk Factors, and Clinical Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07837713
Digestive System Diseases, Gastrointestinal Diseases
Mumbai, Maharashtra, India
View Trial DetailsNCT07753005
Digestive System Diseases, Female Urogenital Diseases and Pregnancy Complications
Nagoya, Aichi-ken, Japan
View Trial DetailsNCT07749300
Acute Upper Gastrointestinal Bleeding, Digestive System Diseases
View Trial DetailsNCT07012863
Aneurysm, Aneurysm, Ruptured
View Trial Details